| Dr Isaac Thomas, MD | |
|
830 Thomas More Pkwy, #202, Edgewood, KY 41017-5102 | |
| (859) 341-6281 | |
| (859) 341-4661 |
| Full Name | Dr Isaac Thomas |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 35 Years |
| Location | 830 Thomas More Pkwy, Edgewood, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881630143 | NPI | - | NPPES |
| 200454710 | Medicaid | IN | |
| 2187664 | Medicaid | OH | |
| 64015413 | Medicaid | KY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davita - 12th St. Covington Dialysis | Covington, KY | Dialysis facility |
| Davita - Turfway Dialysis | Florence, KY | Dialysis facility |
| Davita-walton Dialysis | Walton, KY | Dialysis facility |
| Davita-turfway Pd Training | Florence, KY | Dialysis facility |
| Davita - Crestview Hills Dialysis | Crestview hills, KY | Dialysis facility |
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Florence | Florence, KY | Hospital |
| St Elizabeth Grant | Williamstown, KY | Hospital |
| Christ Hospital | Cincinnati, OH | Hospital |
| St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
News Archive
Researchers in Britain are warning that most medicines for babies and young children contain additives which are often banned from foods and drinks aimed at under-threes.
The BiO Assay, a 3D Bioprinting technology being promoted around the world by the joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), has been awarded a research grant from the Center for Advancement of Science in Space (CASIS)—the sole manager of the International Space Station U.S. National Laboratory.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
Zogenix, Inc. announced today the completion of enrollment in its pivotal Phase 3 efficacy study (Study 801) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.
A growing number of crack cocaine users are renting their cars in exchange for drugs, according to criminologists at the University of Alabama at Birmingham (UAB) Department of Justice Sciences.
› Verified 6 days ago
| Entity Name | Kidney And Hypertension Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306944871 PECOS PAC ID: 9830099985 Enrollment ID: O20040113000581 |
News Archive
Researchers in Britain are warning that most medicines for babies and young children contain additives which are often banned from foods and drinks aimed at under-threes.
The BiO Assay, a 3D Bioprinting technology being promoted around the world by the joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), has been awarded a research grant from the Center for Advancement of Science in Space (CASIS)—the sole manager of the International Space Station U.S. National Laboratory.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
Zogenix, Inc. announced today the completion of enrollment in its pivotal Phase 3 efficacy study (Study 801) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.
A growing number of crack cocaine users are renting their cars in exchange for drugs, according to criminologists at the University of Alabama at Birmingham (UAB) Department of Justice Sciences.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Isaac Thomas, MD 830 Thomas More Pkwy, # 202, Edgewood, KY 41017-5102 Ph: (859) 341-6281 | Dr Isaac Thomas, MD 830 Thomas More Pkwy, #202, Edgewood, KY 41017-5102 Ph: (859) 341-6281 |
News Archive
Researchers in Britain are warning that most medicines for babies and young children contain additives which are often banned from foods and drinks aimed at under-threes.
The BiO Assay, a 3D Bioprinting technology being promoted around the world by the joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), has been awarded a research grant from the Center for Advancement of Science in Space (CASIS)—the sole manager of the International Space Station U.S. National Laboratory.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
Zogenix, Inc. announced today the completion of enrollment in its pivotal Phase 3 efficacy study (Study 801) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.
A growing number of crack cocaine users are renting their cars in exchange for drugs, according to criminologists at the University of Alabama at Birmingham (UAB) Department of Justice Sciences.
› Verified 6 days ago
Alice Hall, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 | |
Colleen M Darnell, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000 Fax: 859-301-4001 | |
Charles M Bernstein, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, St. Elizabeth Healthcare, Edgewood, KY 41017 Phone: 859-301-2423 Fax: 859-301-2066 | |
Vidya Rajaram Devarajan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-757-4446 Fax: 859-344-1999 | |
Dr. Minsig Choi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000 Fax: 859-301-4001 | |
Robert J Wagner, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 | |
Ryan Daniel Weprin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 |